ONCOLOGY THERAPEUTICS NETWORK
Oncology Therapeutics Network is a physician services company. It provides technology solutions, distribution services, practice management tools, and educational programs. The company offers brand and generic pharmaceuticals; Lynx Technology Platform, a charge capture and inventory management and reporting tool; Lynx EMR, a functional subscription-based electronic medical record software service; financial solutions; Web-based portal that manages various clinics' critical processes; and home delivery services for self-administered medications, as well as manages benefits investigation and insurance claims. Oncology Therapeutics Network was founded in 1990 and is headquartered in San Francisco, California.
ONCOLOGY THERAPEUTICS NETWORK
Industry:
Health Care Medical Therapeutics
Founded:
1990-01-01
Address:
South San Francisco, California, United States
Country:
United States
Status:
Active
Contact:
(800)482-6700
Similar Organizations
Anapneo Therapeutics
Anapneo Therapeutics is a medical startup
CorneaCare
Personalized dry eye treatment delivered and monitored.
Current Advisors List
More informations about "Oncology Therapeutics Network"
Oncology Therapeutics Network - Crunchbase
Oncology Therapeutics Network is a physician services company. It provides technology solutions, distribution services, practice management tools, and educational programs. The …See details»
TRIO | Translational Research In Oncology
Since our inception in 1997, TRIO has been at the forefront of clinical cancer research. We have built deep relationships with highly experienced, sought-after Investigators who are pivotal to …See details»
NCI Experimental Therapeutics Clinical Trials Network (ETCTN)
McKesson completes OTN integration; renames unit ‘McKesson …
Oct 28, 2008 This arm of McKesson will now cover McKesson Specialty and the recently acquired Oncology Therapeutics Network. McKesson is now the No. 1 rheumatology …See details»
Oncology Therapeutics Network Corp - Company Profile and News
Company profile page for Oncology Therapeutics Network Corp including stock price, company news, executives, board members, and contact informationSee details»
Overview of the Experimental Therapeutics Clinical Trials ... - Cancer
•The Experimental Therapeutics Clinical Trials Network ... and Cancer Immunotherapy Trials Network (CITN), NCI Community Oncology Program (NCORP) ... Lead Academic …See details»
Initiatives/Programs | CTEP - Cancer
Nov 18, 2024 The NCTN's integrated and collaborative network infrastructure has allowed the Program to meet the challenges of evaluating emerging therapies within its broad investigator …See details»
NCTN: NCI’s National Clinical Trials Network - National …
It means they have been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN). NCTN clinical trials help to establish new standards of care, set the stage for approval of …See details»
Cancer Moonshot Immuno-Oncology Translational Network (IOTN ...
As stated in its 2016 report, the overarching goal of the Cancer Moonshot SM is “to achieve a decade’s worth of progress in preventing, diagnosing, and treating cancer in five years, …See details»
Unification of Efforts to Improve Global Access to …
May 23, 2024 Cancer is a global public health crisis, disproportionately impacting low- and middle-income countries (LMICs). 1 Cancer ranks as a leading cause of death and an important barrier to increasing life expectancy …See details»
Immunotherapy Drug Development Pipeline Shifts …
NEW YORK, NY, APRIL 18, 2023. NEW YORK – After years of broad and rapid growth, immuno-oncology (IO) clinical trials seem to be shifting from the traditional heavyweights to new directions, according to the latest update of …See details»
The National Clinical Trials Network: A Valuable and Undervalued ...
Feb 27, 2023 In a retrospective cohort study evaluating phase III SWOG Cancer Research Network Trials between 1980 and 2017, the positive (and negative) results of nearly half of all …See details»
Meeting Abstract: 2021 ASCO Annual Meeting I - ASCO Publications
May 28, 2021 Background: The National Cancer Institute supports several national trial networks which responded rapidly to the COVID-19 pandemic to overcome operational barriers to …See details»
The NCI Glioblastoma Therapeutics Network (GTN) - Oxford …
Nov 11, 2022 From these recommendations, NCI established the Glioblastoma Therapeutics Network (GTN, RFA-CA-20-047) 3, 4 as a distinct effort from the NCI Brain SPORE grant …See details»
Molecular tumour boards — current and future considerations for ...
Oct 16, 2023 In the era of precision oncology, molecular tumour boards (MTBs) have an increasingly important role in optimizing treatment selection to improve outcomes by reviewing …See details»
Top ten oncology partnerships - Nature
Sep 1, 2022 Foghorn Therapeutics and Loxo Oncology (part of Lilly) $1,680, 10 Dec 2021.See details»
Cancer Moonshot Immuno-Oncology Translational Network at 5 ...
Aug 12, 2023 The Immuno-Oncology Translational Network (IOTN) was established in 2018 as part of the Cancer Moonshot. ... an NCI immunoprevention workshop in 2020, and a 9-webinar …See details»
Global Cancer Drug Development—A Report From the 2022 …
Moreover, although certain new therapeutics have resulted in clearly meaningful gains (such as immunotherapy for melanoma and lung cancer), only 31% of randomized clinical trials (RCTs) …See details»
Clinical Value of Molecular Targets and FDA-Approved ... - JAMA …
However, the safety and effectiveness of several US Food and Drug Administration (FDA)–approved molecular-targeted drugs have not necessarily matched their biochemical …See details»
The Future of RNA Therapeutics Beyond COVID-19 - Technology …
6 days ago The COVID-19 pandemic changed our society, and the technology that powers it, in an instant. Suddenly, remote working, telehealth and online learning boomed. Other changes …See details»